News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
284,421 Results
Type
Article (15035)
Company Profile (299)
Press Release (269081)
Multimedia
Podcasts (78)
Webinars (11)
Section
Business (80934)
Career Advice (169)
Deals (13490)
Drug Delivery (39)
Drug Development (50729)
Employer Resources (31)
FDA (5870)
Job Trends (5284)
News (146443)
Policy (10136)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Standard (2)
Academia (927)
Accelerated approval (19)
Adcomms (14)
Allergies (81)
Alliances (21946)
ALS (125)
Alzheimer's disease (1034)
Antibody-drug conjugate (ADC) (241)
Approvals (6065)
Artificial intelligence (262)
Autoimmune disease (113)
Automation (9)
Bankruptcy (105)
Best Places to Work (4652)
BIOSECURE Act (6)
Biosimilars (100)
Biotechnology (230)
Bladder cancer (101)
Brain cancer (45)
Breast cancer (344)
Cancer (3134)
Cardiovascular disease (237)
Career advice (154)
Career pathing (7)
CAR-T (218)
CDC (5)
Cell therapy (564)
Cervical cancer (14)
Clinical research (43693)
Collaboration (1154)
Company closure (2)
Compensation (596)
Complete response letters (39)
COVID-19 (1102)
CRISPR (86)
C-suite (554)
Cystic fibrosis (112)
Data (4327)
Denatured (15)
Depression (92)
Diabetes (258)
Diagnostics (1396)
Digital health (10)
Diversity (5)
Diversity, equity & inclusion (9)
Drug discovery (188)
Drug pricing (49)
Drug shortages (3)
Duchenne muscular dystrophy (215)
Earnings (32251)
Editorial (25)
Employer branding (4)
Employer resources (29)
Events (52160)
Executive appointments (629)
FDA (7630)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (9)
Frontotemporal dementia (22)
Funding (981)
Gene editing (182)
Generative AI (22)
Gene therapy (488)
GLP-1 (505)
Government (1158)
Grass and pollen (3)
Guidances (171)
Healthcare (6700)
HIV (18)
Huntington's disease (43)
IgA nephropathy (74)
Immunology and inflammation (190)
Immuno-oncology (40)
Indications (66)
Infectious disease (1207)
Inflammatory bowel disease (156)
Inflation Reduction Act (10)
Influenza (38)
Intellectual property (166)
Interviews (18)
IPO (7422)
IRA (12)
Job creations (892)
Job search strategy (135)
JPM (40)
Kidney cancer (9)
Labor market (22)
Layoffs (243)
Leadership (9)
Legal (1425)
Liver cancer (41)
Longevity (12)
Lung cancer (420)
Lymphoma (249)
Machine learning (26)
Management (7)
Manufacturing (376)
MASH (130)
Medical device (2731)
Medtech (2740)
Mergers & acquisitions (6692)
Metabolic disorders (728)
Multiple sclerosis (104)
NASH (13)
Neurodegenerative disease (231)
Neuropsychiatric disorders (70)
Neuroscience (1957)
Neurotech (1)
NextGen: Class of 2026 (2090)
Non-profit (927)
Now hiring (30)
Obesity (330)
Opinion (126)
Ovarian cancer (131)
Pain (102)
Pancreatic cancer (161)
Parkinson's disease (232)
Partnered (12)
Patents (301)
Patient recruitment (329)
Peanut (43)
People (26921)
Pharmaceutical (44)
Pharmacy benefit managers (6)
Phase 1 (15478)
Phase 2 (20297)
Phase 3 (12832)
Pipeline (3265)
Policy (91)
Postmarket research (854)
Preclinical (6536)
Press Release (30)
Prostate cancer (145)
Psychedelics (50)
Radiopharmaceuticals (238)
Rare diseases (651)
Real estate (1484)
Recruiting (12)
Regulatory (9926)
Reports (19)
Research institute (984)
Resumes & cover letters (19)
Rett syndrome (24)
RNA editing (21)
RSV (16)
Schizophrenia (123)
Series A (182)
Series B (136)
Service/supplier (1)
Sickle cell disease (77)
Special edition (18)
Spinal muscular atrophy (119)
Sponsored (16)
Startups (2018)
State (1)
Stomach cancer (5)
Supply chain (32)
Tariffs (18)
The Weekly (62)
Vaccines (335)
Venture capital (69)
Weight loss (173)
Women's health (25)
Worklife (2)
Date
Today (43)
Last 7 days (349)
Last 30 days (1159)
Last 365 days (17898)
2026 (1697)
2025 (18163)
2024 (20639)
2023 (22504)
2022 (26972)
2021 (27956)
2020 (23595)
2019 (16523)
2018 (12016)
2017 (13871)
2016 (11989)
2015 (14569)
2014 (10487)
2013 (7581)
2012 (7620)
2011 (7729)
2010 (7496)
Location
Africa (159)
Alabama (65)
Alaska (3)
Arizona (71)
Arkansas (6)
Asia (18304)
Australia (3131)
California (7097)
Canada (1845)
China (775)
Colorado (247)
Connecticut (256)
Delaware (236)
Europe (39738)
Florida (904)
Georgia (209)
Hawaii (2)
Idaho (18)
Illinois (402)
India (35)
Indiana (164)
Iowa (9)
Japan (223)
Kansas (80)
Kentucky (9)
Louisiana (7)
Maine (11)
Maryland (739)
Massachusetts (5587)
Michigan (111)
Minnesota (248)
Mississippi (3)
Missouri (32)
Montana (16)
Nebraska (5)
Nevada (33)
New Hampshire (22)
New Jersey (1655)
New Mexico (13)
New York (1769)
North Carolina (832)
North Dakota (6)
Northern California (3477)
Ohio (177)
Oklahoma (11)
Oregon (24)
Pennsylvania (1278)
Puerto Rico (9)
Rhode Island (26)
South America (222)
South Carolina (9)
Southern California (2822)
Tennessee (40)
Texas (909)
United States (23409)
Utah (96)
Virginia (136)
Washington D.C. (37)
Washington State (592)
West Virginia (1)
Wisconsin (46)
284,421 Results for "iconic therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Sponsored
Accelerating Timelines and Reducing Cost in Early Clinical Drug Development With ICON’s Accelerated Pharmaceutical Solutions
Innovation drives speed in early phase drug development. ICON’s Accelerated Pharmaceutical Solutions integrate advanced formulation design, real-time dose flexibility, and cutting-edge CMC expertise to transform complexity into clarity. By uniting science, technology, and strategy, biotechs can move faster, smarter, and with confidence—turning obstacles into opportunities for breakthrough success.
December 8, 2025
·
5 min read
·
Arjen Akkerman
Press Releases
ICON’s Accellacare Site Network Expands Oncology Research Capabilities With New Cancer Institute Partnership
January 27, 2026
·
3 min read
Press Releases
ICON plc to Present at the 2025 Jefferies London Healthcare Conference
November 13, 2025
·
2 min read
Press Releases
ICON Announces CEO Transition
September 5, 2025
·
4 min read
Press Releases
ICON Reports Third Quarter 2025 Results
October 22, 2025
·
15 min read
Press Releases
Hoth Therapeutics Announces Engagement with ICON and Expansion of Phase II Clinical Trial for HT-001 in Europe
July 30, 2025
·
4 min read
Press Releases
ICON’s Leadership and Performance in Phase 1 Clinical Trials Recognised in Independent Industry Benchmarking Report
July 17, 2025
·
3 min read
Press Releases
ICON plc Schedules Third Quarter 2025 Earnings Conference Call
September 25, 2025
·
2 min read
Press Releases
ICON plc to Participate at Upcoming September 2025 Investor Conferences
September 2, 2025
·
2 min read
Press Releases
ICON Announces Results of Annual General Meeting
July 24, 2025
·
3 min read
1 of 28,443
Next
